Login to Your Account

Xenova Adding To Pipeline Via £8.5M KS Biomedix Acquisition

By Nuala Moran

Wednesday, August 20, 2003
LONDON - Consolidation continues in the UK as Xenova Group plc announced an agreed-to £8.48 million (US$13.5 million) all-share takeover offer for KS Biomedix plc (KSB). (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription